Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 15

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 15
---
 (v) Paul Field and our management
has no reason to believe that any nominee will be unable to serve. Their biographies are provided at pages 9 to 10. The biographies of
each of the nominees contains information regarding the person’s service as a director, business experience, public-company director
positions held currently or at any time during the last five years, information regarding involvement in certain legal or administrative
proceedings, if applicable, and the experiences, qualifications, attributes or skills that caused the Nominating and Corporate Governance
Committee and the Board to determine that the person should serve as a director for the Company. In addition to the information presented
above regarding each nominee’s specific experience, qualifications, attributes and skills that led our Board to the conclusion that
he or she should serve as a director, we also believe that all of our director nominees have a reputation for integrity, honesty and adherence
to high ethical standards. They each have demonstrated business acumen and an ability to exercise sound judgment, as well as a commitment
of service to 60 Degrees Pharmaceuticals and our Board. Finally, we value their significant experience on other public company boards
of directors and board committees.

A nominee will be elected as a director if he
receives a plurality of the votes cast, in person or by proxy, at the Annual Meeting. This means that the nominees for election as director
who receive the highest number of affirmative votes at the Annual Meeting will be elected as director. Withheld votes and broker non-votes
will have no effect on the outcome of the vote.

Unless otherwise instructed, the proxy holders
will vote the proxies received by them “FOR” each of the nominees named above. If any nominee becomes unavailable for
election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead be voted for the election
of a substitute nominee proposed by our Board.

<div align='center'>The Board recommends that you vote “FOR” the election of all of these nominees.

8

DIRECTORS AND EXECUTIVE OFFICERS</div>

The following table sets forth certain information
regarding our directors and executive officers:

| Name(1)        
 Geoffrey Dow   |     | Age 
  52 |     | Position                                        
 Chief Executive Officer, President and Director |     | Director      
 Since         
 June 1, 2022  |     | Board Committee                                                      
 None                                                                 |
|:---------------|:----|----:|:----|:------------------------------------------------|: